Karyopharm Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/13/2024 | 7.65 M | $6.35 M | 0.00% | 6.12% |
| EVERSEPT PARTNERS, LP | 11/14/2024 | 5.55 M | $4.60 M | 11.24% | 4.44% |
| PALO ALTO INVESTORS LP | 11/14/2024 | 5.10 M | $4.23 M | 0.00% | 4.08% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 4.32 M | $3.59 M | 0.00% | 3.46% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.64 M | $3.02 M | 100.00% | 2.91% |
| CITADEL ADVISORS LLC | 11/14/2024 | 3.10 M | $2.58 M | 0.07% | 2.48% |
| MARSHALL WACE, LLP | 11/14/2024 | 2.08 M | $1.73 M | -19.32% | 1.67% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 2.02 M | $1.68 M | 0.00% | 1.61% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 1.78 M | $1.47 M | 80.56% | 1.42% |
| C WORLDWIDE GROUP HOLDING A/S | 11/05/2024 | 1.50 M | $1.25 M | 0.00% | 1.20% |
| JPMORGAN CHASE & CO | 11/08/2024 | 1.39 M | $1.15 M | 8.61% | 1.11% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.36 M | $1.13 M | 3.34% | 1.08% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.34 M | $1.11 M | -41.64% | 1.07% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.26 M | $1.04 M | -40.01% | 1.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.24 M | $1.03 M | 64.16% | 0.99% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.20 M | $999,327 | 0.60% | 0.96% |
| UBS OCONNOR LLC | 11/14/2024 | 1.20 M | $992,824 | 8.51% | 0.96% |
| ALPHACENTRIC ADVISORS LLC | 10/30/2024 | 1.13 M | $933,750 | 0.00% | 0.90% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 1.05 M | $869,339 | 24.08% | 0.84% |
| ALTIUM CAPITAL MANAGEMENT LP | 11/14/2024 | 740,000 | $614,200 | 0.00% | 0.59% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 558,466 | $463,527 | 0.00% | 0.45% |
| MACQUARIE GROUP LTD | 11/14/2024 | 500,000 | $415,000 | -1.12% | 0.40% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 496,236 | $411,876 | -12.78% | 0.40% |
| BIRCHVIEW CAPITAL, LP | 11/14/2024 | 469,832 | $389,961 | 0.00% | 0.38% |
| STATE STREET CORP | 11/14/2024 | 409,510 | $339,893 | -9.76% | 0.33% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 409,355 | $339,764 | 0.00% | 0.33% |
| FMR LLC | 11/13/2024 | 369,723 | $306,870 | 26.09% | 0.30% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 368,511 | $304,000 | 89.79% | 0.29% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 302,548 | $251,115 | -31.78% | 0.24% |
| ATOM INVESTORS LP | 11/14/2024 | 259,824 | $215,654 | -0.77% | 0.21% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 239,500 | $198,785 | -9.45% | 0.19% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 228,941 | $190,022 | -23.35% | 0.18% |
| EXCHANGE TRADED CONCEPTS, LLC | 10/10/2024 | 218,791 | $181,597 | 34.91% | 0.18% |
| JANE STREET GROUP, LLC | 11/15/2024 | 204,750 | $169,942 | -86.79% | 0.16% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 192,678 | $159,923 | 0.00% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 183,300 | $152,139 | -25.12% | 0.15% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 166,316 | $138,042 | 0.00% | 0.13% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 134,700 | $112,000 | 38.72% | 0.11% |
| UBS GROUP AG | 11/14/2024 | 134,478 | $111,617 | -4.41% | 0.11% |
| WOODLINE PARTNERS LP | 11/14/2024 | 134,112 | $111,313 | 0.00% | 0.11% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 11/12/2024 | 132,435 | $25,600 | 100.00% | 0.11% |
| MORGAN STANLEY | 11/14/2024 | 123,647 | $102,628 | -38.18% | 0.10% |
| BARCLAYS PLC | 11/19/2024 | 95,767 | $79,000 | -89.03% | 0.08% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 91,091 | $75,606 | 0.00% | 0.07% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 85,930 | $71,322 | 519.72% | 0.07% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2024 | 82,446 | $68,430 | -50.13% | 0.07% |
| CITADEL ADVISORS LLC | 11/14/2024 | 64,000 | $53,120 | -19.60% | 0.05% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 62,026 | $51,482 | -41.74% | 0.05% |
| INVESCO LTD. | 11/12/2024 | 58,152 | $48,266 | 43.55% | 0.05% |
| CERITY PARTNERS LLC | 11/12/2024 | 51,533 | $42,773 | 100.00% | 0.04% |
Karyopharm Therapeutics Inc.institutional Ownership - FAQ's
During the previous two years, 156 institutional investors and hedge funds held shares of Karyopharm Therapeutics Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 7.65 M
Eversept Partners, LP: 5.55 M
Palo Alto Investors LP: 5.1 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 4.32 M
BlackRock Funding, Inc. /DE: 3.64 M
CITADEL ADVISORS LLC: 3.1 M
47.52% of Karyopharm Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 66.49 M shares in the last 24 months. This purchase volume represents approximately $41.23 M in transactions.